Acorda Therapeutics, Inc. (ACOR) financial statements (2020 and earlier)

Company profile

Business Address 420 SAW MILL RIVER ROAD
ARDSLEY, NY 10502
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments126446307159353308
Cash and cash equivalents62294307159153182
Short-term investments64152  200125
Restricted cash and investments1310061
Receivables222381523132
Inventory, net of allowances, customer advances and progress billings2529    
Inventory2529    
Prepaid expense121913131616
Deferred tax assets    18
Other current assets4102687
Other undisclosed current assets  38433627
Total current assets:201528442273451409
Noncurrent Assets
Operating lease, right-of-use asset23
Property, plant and equipment1436137344046
Intangible assets, net (including goodwill)4027117171,023614616
Goodwill 282287281184183
Intangible assets, net (excluding goodwill)402429431742431433
Restricted cash and investments30     
Deferred costs  2234
Other noncurrent assets001656
Deferred tax assets, net   2(24)
Other undisclosed noncurrent assets   4 24
Total noncurrent assets:5997727561,070665672
TOTAL ASSETS:8001,3001,1981,3421,1161,081
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities651261271328087
Accounts payable264927271418
Accrued liabilities39771001056656
Employee-related liabilities     13
Debt811701
Business combination, contingent consideration, liability25    
Deferred revenue and credits99938
Other undisclosed current liabilities1197 1(12)
Total current liabilities:8614014414891114
Noncurrent Liabilities
Long-term debt and lease obligation241343334324297290
Long-term debt, excluding current maturities218343334324297290
Operating lease, liability23
Liabilities, other than long-term debt155183155120114112
Deferred revenue and credits23324251
Deferred income tax liabilities10
Liability for uncertainty in income taxes7877  
Other liabilities01212999
Business combination, contingent consideration, liability78163113726453
Derivative instruments and hedges, liabilities59     
Other undisclosed noncurrent liabilities6224486  
Total noncurrent liabilities:403547534530411402
Total liabilities:489688678678501517
Stockholders' equity
Stockholders' equity attributable to parent311612520664603540
Common stock000000
Treasury stock, value(1)(2)(0)(0)(0)(0)
Additional paid in capital9791,005969921813761
Accumulated other comprehensive income (loss)(1)37(13)(0)(0)
Accumulated deficit(667)(394)(455)(244)(209)(220)
Total stockholders' equity:311612520664603540
Other undisclosed liabilities and equity    1224
TOTAL LIABILITIES AND EQUITY:8001,3001,1981,3421,1161,081

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues192471588520493402
Revenue, net588520493401
Cost of revenue(35)(144)(162)(117)(92)(80)
Cost of goods and services sold(35)(99)(135)(107)(92)(80)
Gross profit:158327427403400322
Operating expenses(530)(289)(660)(439)(459)(365)
Other undisclosed operating income61   9280
Operating income (loss):(312)38(233)(36)3436
Nonoperating income (expense)37(18)(19)(6)(15)(8)
Investment income, nonoperating440001
Other nonoperating income (expense)00(1)1000
Interest and debt expense55(22)(19)(17)(15)(9)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(55)221917159
Income (loss) from continuing operations before equity method investments, income taxes:(274)20(252)(42)1928
Other undisclosed income from continuing operations before income taxes 0    
Income (loss) from continuing operations before income taxes:(274)20(252)(42)1928
Income tax expense (benefit)113297(8)(10)
Net income (loss):(273)34(223)(36)1118
Net income attributable to noncontrolling interest   1  
Net income (loss) available to common stockholders, diluted:(273)34(223)(35)1118

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(273)34(223)(36)1118
Other comprehensive income (loss)(4)(4)20(13)  
Comprehensive income (loss):(277)30(204)(48)1118
Comprehensive income, net of tax, attributable to noncontrolling interest   0  
Other undisclosed comprehensive loss, net of tax, attributable to parent    (0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(277)30(204)(48)1118

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: